Mark Coleman - 20 Feb 2026 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Nick Pizzie, Attorney-in-Fact
Issuer symbol
AXSM
Transactions as of
20 Feb 2026
Net transactions value
+$61,801
Form type
4
Filing time
23 Feb 2026, 19:23:38 UTC
Previous filing
10 Feb 2026
Next filing
25 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coleman Mark Director C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK /s/ Nick Pizzie, Attorney-in-Fact 23 Feb 2026 0001658379

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Options Exercise $61,801 +12,485 +23% $4.95 65,890 20 Feb 2026 Direct F1
holding AXSM Common Stock 403,856 20 Feb 2026 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -12,485 -47% $0.000000 13,971 20 Feb 2026 Common Stock 12,485 $4.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares.
F2 Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.